Colossal Biosciences, a Dallas-based biotech startup focused on reviving extinct species, raised $120 million in a Series C fundraising round led by Peter Jackson, U.S. Innovative Technology Fund, and Bob Nelsen.
More on TechStartups →
Colossal Biosciences, a Dallas-based biotech startup focused on reviving extinct species, raised $120 million in a Series C fundraising round led by Peter Jackson, U.S. Innovative Technology Fund, and Bob Nelsen.
More on TechStartups →
Warhound, a Texas-based advanced genetics for working dogs, raised $200...
QuantrolOx, an Espoo, Finland-based quantum control software maker, raised...
Universal Quantum, a Haywards Heath, United Kingdom-based trapped-ion...
Quanfluence, a Bengaluru, India-based photonic quantum computing company,...
Autobia, a Dammam, Saudi Arabia-based auto parts platform, raised $12...
Oratomic, a Pasadena, CA-based fault-tolerant quantum computing company,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.